Andrea Montisci Selected Research

Andrea Montisci Research Topics

4	Cardiogenic Shock 01/2022 - 10/2016
4	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 02/2021 - 05/2015
3	Heart Failure 01/2022 - 01/2021
3	Myocardial Infarction 01/2022 - 08/2016
3	Hypoxia (Hypoxemia) 03/2018 - 05/2015
2	Shock 12/2023 - 10/2016
2	Neoplasms (Cancer) 09/2021 - 01/2021
2	Cardiotoxicity 09/2021 - 01/2021
2	COVID-19 02/2021 - 07/2020
2	Inflammation (Inflammations) 01/2021 - 03/2018
2	Thrombosis (Thrombus) 07/2020 - 01/2019
1	Hemorrhage 12/2023
1	Pulmonary Hypertension 01/2022
1	Hypothermia 01/2022
1	Lung Neoplasms (Lung Cancer) 09/2021
1	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 09/2021
1	Left Ventricular Dysfunction 09/2021
1	B-Cell Lymphoma (Lymphoma, B Cell) 09/2021
1	Leukemia 09/2021
1	Atrial Fibrillation 08/2021
1	Cardiomyopathies (Cardiomyopathy) 01/2021
1	Cardiac Arrhythmias (Arrythmia) 01/2021
1	Coronary Vasospasm (Coronary Artery Vasospasm) 01/2021
1	Atherosclerosis 01/2021
1	Takotsubo Cardiomyopathy 01/2021
1	Hyperplasia 07/2020
1	Mitral Valve Insufficiency (Mitral Regurgitation) 04/2020
1	Stroke (Strokes) 01/2018

1	CatecholaminesIBA 12/2023
1	Chimeric Antigen ReceptorsIBA 09/2021
1	Monoclonal AntibodiesIBA 09/2021
1	Trastuzumab (Herceptin)FDA Link 09/2021
1	1,1'- (4,4,7,7- tetramethyl- 4,7- diazaundecamethylene)bis- 4- (3- methyl- 2,3- dihydro(benzo- 1,3- thiazole)- 2- methylidene)quinolinium (TOTO)IBA 07/2020
1	CytokinesIBA 01/2019
1	Oxygen (Dioxygen)IBA 03/2018

8	Therapeutics 09/2021 - 08/2016
6	Extracorporeal Membrane Oxygenation 01/2022 - 05/2015
3	Heart-Assist Devices 12/2023 - 01/2019
2	Catheters 08/2021 - 03/2021
2	Counterpulsation (External Counterpulsation) 04/2018 - 10/2016
1	Immunotherapy 09/2021
1	Drug Therapy (Chemotherapy) 01/2021
1	Heart Transplantation (Grafting, Heart) 01/2021
1	Mitral Valve Annuloplasty 04/2020
1	Mechanical Ventilators (Ventilator) 03/2018
1	Artificial Respiration (Mechanical Ventilation) 03/2018
1	Blood Transfusion (Blood Transfusions) 01/2018